Literature DB >> 15682969

Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions.

F J Moet1, A Meima, L Oskam, J H Richardus.   

Abstract

Existing knowledge on risk factors for the development of clinical leprosy among contacts of known leprosy patients is reviewed with the aim to identify factors associated with leprosy among contacts that have potential for developing effective targeted interventions in leprosy control. Different definitions of 'contact' have been used and most studies on this subject were among so-called household members. Yet several studies indicate that contacts found in other places than the household are also at risk of developing leprosy. The type of leprosy and the bacterial index are the main patient-related factors involved in transmission, but also contacts of PB patients have a higher risk of contracting leprosy as compared to the general population. The most important contact-related factors are the closeness and intensity of the contact and inherited susceptibility, while the role of age and sex of the contacts is not clear. The role of socio-economic factors is also vague. The significance of immunological and molecular markers in relation to risk of transmitting or developing leprosy is not yet fully understood, but there is an indication that contacts who are sero-positive for anti-PGL-I antibodies are at increased risk of developing clinical leprosy. The presence of a BCG scar is likely to be related to a lower risk. Analogies with tuberculosis suggest that the 'stone-in-the-pond' approach to control may be applicable to leprosy too. Sputum smear negative tuberculosis patients are known to spread the bacteria to others. This analogy strengthens the suggestion that the contacts of paucibacillary leprosy cases should also be included in contact tracing and examination. It is concluded that targeted interventions should be aimed at close contacts of both MB and PB patients inside and outside the household, particularly when genetically related.

Entities:  

Mesh:

Year:  2004        PMID: 15682969

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  27 in total

1.  ML1419c peptide immunization induces Mycobacterium leprae-specific HLA-A*0201-restricted CTL in vivo with potential to kill live mycobacteria.

Authors:  Annemieke Geluk; Susan J F van den Eeden; Karin Dijkman; Louis Wilson; Hee Jin Kim; Kees L M C Franken; John S Spencer; Maria C V Pessolani; Geraldo M B Pereira; Tom H M Ottenhoff
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

2.  Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.

Authors:  R M Oliveira; E M Hungria; A de Araújo Freitas; A L O M de Sousa; M B Costa; S G Reed; M S Duthie; M M A Stefani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-12       Impact factor: 3.267

3.  Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles.

Authors:  Nathan A Groathouse; Amol Amin; Maria Angela M Marques; John S Spencer; Robert Gelber; Dennis L Knudson; John T Belisle; Patrick J Brennan; Richard A Slayden
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

Review 4.  Leprosy and the human genome.

Authors:  Elizabeth A Misch; William R Berrington; James C Vary; Thomas R Hawn
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

5.  Geographic information systems and applied spatial statistics are efficient tools to study Hansen's disease (leprosy) and to determine areas of greater risk of disease.

Authors:  José Wilton Queiroz; Gutemberg H Dias; Maurício Lisboa Nobre; Márcia C De Sousa Dias; Sérgio F Araújo; James D Barbosa; Pedro Bezerra da Trindade-Neto; Jenefer M Blackwell; Selma M B Jeronimo
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

6.  Factors associated with the development of leprosy in Brazilian contacts: a systematic review.

Authors:  Edilamar Silva de Alecrin; Ana Laura Grossi de Oliveira; Nathália Sernizon Guimarães; Sandra Lyon; Maria Auxiliadora Parreiras Martins; Manoel Otávio da Costa Rocha
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-09-30       Impact factor: 2.169

7.  Social distance and spatial distance are not the same, observations on the use of GIS in leprosy epidemiology.

Authors:  T A Hoeven; E A J Fischer; D Pahan; J H Richardus
Journal:  Epidemiol Infect       Date:  2008-02-13       Impact factor: 2.451

8.  Nasal mucosa study of leprosy contacts with positive serology for the phenolic glycolipid 1 antigen.

Authors:  Ana Cristina da Costa Martins; Alice Miranda; Maria Leide Wan-del-Rey de Oliveira; Samira Bührer-Sékula; Alejandra Martinez
Journal:  Braz J Otorhinolaryngol       Date:  2010 Sep-Oct

9.  Factors associated with anti-phenolic glycolipid-I seropositivity among the household contacts of leprosy cases.

Authors:  Ana Paula Mendes Carvalho; Angélica da Conceição Oliveira Coelho Fabri; Rodrigo Corrêa Oliveira; Francisco Carlos Félix Lana
Journal:  BMC Infect Dis       Date:  2015-05-30       Impact factor: 3.090

10.  The prevalence of previously undiagnosed leprosy in the general population of northwest bangladesh.

Authors:  Fake J Moet; Ron P Schuring; David Pahan; Linda Oskam; Jan Hendrik Richardus
Journal:  PLoS Negl Trop Dis       Date:  2008-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.